PHINIA Inc. PHIN
Set alert
69.63 USD -1.17 -1.65%
As of Nov 3, 11:33 AM ET
68.46 Day range 71.41
51.38 52-week range 86.94
- YTD
- +11.06%
- 1 year
- +32.14%
- Open
- 71.06
- Prev close
- 70.79
- Mkt cap
- 2.50B
- Vol
- 109.17K
- Avg vol
- 387.35K
- EPS
- 4.93
- P/E
- 14.11
- Div yield
- 1.97%
More statistics
- Low
- 68.46
- High
- 71.41
- Forward P/E
- 10.25
- Beta
- 1.10
- Short ratio
- 7.59
- Inst. own
- 106.81%
- Dividend
- 1.20
- Ex-div date
- Sep 3, 2026
- Earnings
- Feb 11, 2027
- 50-d avg
- 62.10
- 200-d avg
- 71.36
- 1y target
- 88.40
MAX chart
Events in this range
- Sep 11, 2023Dividend: 0.25
- Nov 30, 2023Dividend: 0.25
- Feb 23, 2024Dividend: 0.25
- May 23, 2024Dividend: 0.25
- Aug 23, 2024Dividend: 0.25
- Nov 25, 2024Dividend: 0.25
- Feb 28, 2025Dividend: 0.27
- Jun 2, 2025Dividend: 0.27
- Aug 22, 2025Dividend: 0.27
- Oct 28, 2025Earnings: 1.59; estimate 1.17; surprise 35.9%
- Nov 24, 2025Dividend: 0.27
- Feb 12, 2026Earnings: 1.18; estimate 1.35; surprise -12.59%
- Feb 26, 2026Downgrade: Freedom Broker · Buy → Hold
- Mar 6, 2026Dividend: 0.3
- Apr 30, 2026Earnings: 1.29; estimate 1.13; surprise 14.16%
- Jun 9, 2026Dividend: 0.3
- Jun 12, 2026Rating: Keybanc · — → Overweight
- Jul 9, 2026Rating: UBS · Neutral → Neutral
- Jul 30, 2026Earnings: 1.53; estimate 1.57; surprise -2.55%
- Jul 31, 2026Rating: UBS · Neutral → Neutral
- Sep 4, 2026Dividend: 0.3
- Oct 7, 2026Rating: UBS · Neutral → Neutral
- Oct 29, 2026Earnings: 1.83; estimate 1.68; surprise 8.93%
- Oct 30, 2026Rating: UBS · Neutral → Neutral
Signals (47)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jul 13, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 6, 2026 | 4 months ago |
| SMA: Bearish | Jun 29, 2026 | 4 months ago |
| RSI: Overbought | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | May 4, 2026 | 6 months ago |
| RSI: Overbought | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| RSI: Overbought | Dec 29, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 1, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| RSI: Overbought | Aug 18, 2025 | 1 year ago |
Newest 20 of 47.
Analyst view
Consensus: buy
Buy
Price target (mean) 88.40 +27.0% upside
Now 69.63
- Target (low)
- 69.00
- Target (mean)
- 88.40
- Target (high)
- 105.00
Ratings (0m) 5 4 buy · 1 hold · 0 sell
- Strong buy1
- Buy3
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.62 | 1.55 – 1.69 | 1.18 | +37.4% | 916.55M | +3.1% | 2 |
| Next quarter | 1.46 | 1.40 – 1.52 | 1.29 | +13.2% | 919.13M | +4.7% | 2 |
| Current year | 6.22 | 6.19 – 6.25 | 4.96 | +25.4% | 3.65B | +4.8% | 2 |
| Next year | 6.83 | 6.50 – 7.21 | 6.22 | +9.9% | 3.77B | +3.2% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 7, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 31, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 9, 2026 | UBS | Maintained | Neutral | Neutral |
| Jun 12, 2026 | Keybanc | Initiated | — | Overweight |
| Feb 26, 2026 | Freedom Broker | Downgrade | Buy | Hold |
| Jan 16, 2026 | Freedom Broker | Initiated | — | Buy |
| Jan 14, 2026 | UBS | Maintained | Neutral | Neutral |
| Dec 30, 2025 | Northland Capital Markets | Maintained | Outperform | Outperform |
| Oct 29, 2025 | UBS | Maintained | Neutral | Neutral |
| Oct 6, 2025 | UBS | Maintained | Neutral | Neutral |
| Sep 10, 2025 | B of A Securities | Maintained | Buy | Buy |
| Aug 12, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 25, 2025 | UBS | Maintained | Neutral | Neutral |
| Jul 14, 2025 | UBS | Maintained | Neutral | Neutral |
| May 19, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 15, 2025 | B of A Securities | Maintained | Buy | Buy |
| Apr 10, 2025 | UBS | Downgrade | Buy | Neutral |
| Apr 10, 2025 | B of A Securities | Initiated | — | Buy |
| Mar 24, 2025 | CL King | Initiated | — | Buy |
| Jan 30, 2025 | Northland Capital Markets | Initiated | — | Outperform |
| Jan 16, 2025 | UBS | Maintained | Buy | Buy |
| Sep 25, 2024 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Sep 4, 2024 | UBS | Initiated | — | Buy |
| Mar 12, 2024 | Morgan Stanley | Initiated | — | Overweight |
| Mar 11, 2024 | Morgan Stanley | Initiated | — | Overweight |
| Sep 5, 2023 | Exane BNP Paribas | Initiated | — | Outperform |